Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Analysis: China plays hardball with ex-diplomat's seizure

Dec 12, 2018

BEIJING — China is playing hardball with the detention of a former Canadian diplomat days after Canada arrested a leading Chinese executive. In many ways it looks like a classic Chinese response to perceived slights: Deny any wrongdoing, seize the moral high ground and exert maximum pressure to extract concessions. But Beijing's detention of Michael Kovrig also reflects an increasingly bold approach to international disputes under President Xi Jinping, who has overseen a vast expansion of China's diplomatic, military and economic power. China has often retaliated against foreign governments and corporations in diplomatic disputes, but rarely by holding a foreign...

China and US discuss plans for trade talks

Dec 12, 2018

BEIJING — China's economy czar and U.S. trade envoys discussed plans for talks on a tariff battle, the government said Tuesday, indicating that negotiations are going ahead despite tension over the arrest of a Chinese tech executive. Vice Premier Liu He talked by phone with Treasury Secretary Steven Mnuchin and U.S. Trade Representative Robert Lighthizer about "the promotion of the next economic and trade consultations," said a two-sentence Commerce Ministry statement. It gave no other details. Lighthizer's office confirmed the phone call with Liu but provided no additional information. The announcement indicated that talks are on track despite China's weekend...

Asian shares mixed on concerns over trade, economic outlook

Dec 12, 2018

SINGAPORE — Asian markets were mixed Tuesday in narrow trading on doubts that U.S. and China can manage to resolve their festering trade dispute. KEEPING SCORE: Japan's benchmark Nikkei 225 lost 0.4 percent to 21,127.00 and South Korea's Kospi added less than 0.1 percent to 2,055.07. Hong Kong's Hang Seng edged 0.1 percent higher to 25,768.25. The Shanghai Composite rose 0.3 percent to 2,586.47. Australia's S&P/ASX 200 added 0.2 percent to 5,562.50. Shares rose in Taiwan but fell in Singapore and Indonesia. WALL STREET: Buying of technology companies spurred gains for U.S. indexes after steep losses in early trading. China...

Gene-editing Chinese scientist kept much of his work secret

Dec 12, 2018

SHENZHEN, China — The Chinese scientist who says he helped make the world's first gene-edited babies veered off a traditional career path, keeping much of his research secret in pursuit of a larger goal — making history. He Jiankui's outsized aspirations began to take shape in 2016, the year after another team of Chinese researchers sparked global debate with the revelation that they had altered the DNA of human embryos in the lab. He soon set his mind on pushing the boundaries of medical ethics even further. The China-born, U.S.-trained scientist once confided to his former Stanford University adviser his...

World markets rise despite Trump's renewed tariff threat

Dec 12, 2018

SINGAPORE — World markets were mostly higher on Tuesday despite U.S. President Donald Trump saying it's "highly unlikely" he'll hold off on raising tariffs ahead of a closely-watched meeting with his Chinese counterpart. KEEPING SCORE: Germany's DAX index gained 0.3 percent to 11,381.78 and France's CAC 40 added 0.2 percent to 5,006.05. Britain's FTSE 100 index was flat at 7,037.15. Wall Street was set for a moderate start. Futures for the broad S&P 500 index rose 0.1 percent to 2,671.20. Dow futures also gained 0.1 percent to 24,621.00. ASIA'S DAY: Japan's benchmark Nikkei 225 added 0.6 percent to 21,952.40 and...

Sign up now!